expects to drive sales through its focus on growth opportunities in Indonesia and the private market in Malaysia while awaiting for the extension of its logistics and distribution agreement with the Health Ministry.
The logistic and distribution agreement is targeted to be executed in the fourth quarter of 2022, the pharmaceutical company said in a filing with Bursa Malaysia yesterday.
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Источник: staronline - 🏆 4. / 75 Прочитайте больше »